People with Diabetes Tell FDA Not to Lock them Out of Monitoring and Treatment Devices

In response to an FDA request for public comment, more than a thousand individuals who use digital devices for diabetes monitoring and treatment have urged the agency not to lock them out in the name of cybersecurity.